Redeye remains positive to Strax after a solid Q3-profitability beat. Following the report, we have minor changes to our near-term estimates while most notably increased our Q4 EBIT-estimate by +30%. We continue to believe that the market underestimates STRAX's ability to create long term value, and our base case valuation offers solid upside potential.